Mirae Asset Global Investments’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Mirae Asset Global Investments’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-43,661	Closed	-$615K	–	2627
2024 Q1	$615K	Buy	43,661 +2,900	+7%	+$20K	﹤0.01%	1808
2023 Q4	$265K	Buy	40,761 +6,745	+20%	+$43.5K	﹤0.01%	2245
2023 Q3	$321K	Sell	34,016 -757	-2%	-$9.11K	﹤0.01%	2101
2023 Q2	$482K	Buy	34,773 +294	+0.9%	+$5.01K	﹤0.01%	1969
2023 Q1	$647K	Buy	34,479 +6,697	+24%	+$110K	﹤0.01%	1805
2022 Q4	$383K	Buy	27,782 +2,804	+11%	+$42.9K	﹤0.01%	2032
2022 Q3	$478K	Buy	24,978 +7,820	+46%	+$142K	﹤0.01%	1890
2022 Q2	$262K	Buy	+17,158	New	+$254K	﹤0.01%	2051

Other funds holding CDMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PAIM

Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Mirae Asset Global Investments's CDMO Position: Q2 2024 in Review

Mirae Asset Global Investments sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q2 2024, closing a stake of 43,661 shares — an estimated $615K sold.

Mirae Asset Global Investments first reported a position in CDMO in Q2 2022 and held it in 8 quarters. The position peaked at $647K in Q1 2023. 172 funds tracked by Wall St. Rank hold CDMO as of Q2 2024.

Mirae Asset Global Investments reported no remaining Avid Bioservices, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Mirae Asset Global Investments sold 43,661 Avid Bioservices, Inc. Common Stock shares in Q2 2024, an estimated $615K.
Mirae Asset Global Investments first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2022 and held it in 8 quarters.
Mirae Asset Global Investments's Avid Bioservices, Inc. Common Stock position peaked at $647K in Q1 2023.
172 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q2 2024.

Based on Mirae Asset Global Investments's 13F filing for Q2 2024, filed 30 Jul 2024.